The pandemic has greatly accelerated the adoption of telehealth, awakening clinicians and patients to its many benefits. It’s clear that telehealth and virtual visits will only continue to gain momentum as an important care delivery method – not a replacement for in-person care, but a tool that meets previously unmet needs and helps overcome barriers to access. From remote monitoring devices to digital therapeutics, to wearables and AI-powered insights, these innovations will help bridge the gap between virtual care and in-person care, driving better patient outcomes.
Intel and Cleveland Clinic have collaborated to provide innovative telehealth solutions during the COVID-19 pandemic, including at-home monitoring of patients with COVID-19, and pulmonary outpatients with borderline low oxygen saturations (89-95%), which may be acute (post COVID) or chronic. Although these patients do not qualify for supplemental oxygen, home monitoring provides a real-world representation of their saturations in their day-to-day activities and any sudden changes. Patients are using the platform to enter symptoms, temperature and oxygen levels once a day, which providers use to assess their progress and address if conditions worsen.
In this podcast with the ATA, Intel and Cleveland Clinic discussed the impact of COVID-19 on telehealth adoption and looking beyond, how innovative solutions like their collaboration are helping manage patient care remotely, and how the industry can overcome barriers to help telehealth realize its full potential. Telehealth is here to stay, and with the right investments and dedication to innovation, we can provide better healthcare to more people across the globe – an outcome we can all be proud of.
Dr. Fabio Potenti, Chief Medical Officer, Cleveland Clinic Florida